- Home
- ALVO vs LMRI Comparison
ALVO vs LMRI Comparison
Compare ALVO & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALVO | LMRI |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | ALVO | LMRI |
|---|---|---|
| Price | $5.40 | $12.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $9.25 | ★ $22.67 |
| AVG Volume (30 Days) | 366.8K | ★ 654.9K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | $573,350,000.00 | ★ $1,003,375,000.00 |
| Revenue This Year | $20.85 | $9.29 |
| Revenue Next Year | $44.49 | $5.01 |
| P/E Ratio | $22.36 | ★ N/A |
| Revenue Growth | ★ 45.55 | 1.38 |
| 52 Week Low | $4.32 | $12.15 |
| 52 Week High | $13.08 | $19.45 |
Technical Indicators
Market Signals| Indicator | ALVO | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 59.76 | 19.41 |
| Support Level | $5.21 | $12.42 |
| Resistance Level | $5.58 | $14.03 |
| Average True Range (ATR) | 0.21 | 1.14 |
| MACD | 0.08 | -0.28 |
| Stochastic Oscillator | 82.80 | 0.79 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About LMRI Lumexa Imaging Holdings Inc. Common Stock
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.